Glucocorticoids unleash immune-dependent melanoma control through inhibition of the GARP/TGFβ axis [RNA-seq]
RNA-seq (gene expression) · mouse · 31 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Mus musculus (mouse)
- Samples
- 31 samples: 8 conditions, mostly with about 5 replicates eachGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Glucocorticoids Unleash Immune-dependent Melanoma Control through Inhibition of the GARP/TGFβ AxisCancer discovery · 2026
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE286519_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1209855 and SRA study SRP556900. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 31 samples.
How we read this: 8 replicated groups read from 31 sample titles; they account for 31 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8728811 Control treated parental tumor 1 Control treated parenta…
- GSM8728812 Control treated parental tumor 2 Control treated parenta…
- GSM8728813 Control treated parental tumor 3 Control treated parenta…
- GSM8728814 Control treated parental tumor 4 Control treated parenta…
- GSM8728815 Control treated parental tumor 5 Control treated parenta…
- GSM8728816 Glucocorticoid treated parental tumor 1 Glucocorticoid treated …
- GSM8728817 Glucocorticoid treated parental tumor 2 Glucocorticoid treated …
- GSM8728818 Glucocorticoid treated parental tumor 3 Glucocorticoid treated …
- GSM8728819 Glucocorticoid treated parental tumor 4 Glucocorticoid treated …
- GSM8728820 Glucocorticoid treated parental tumor 5 Glucocorticoid treated …
- GSM8728821 Control treated glucocorticoid receptor knockout (GRKO) tumor 1 Control treated glucoco…
- GSM8728822 Control treated glucocorticoid receptor knockout (GRKO) tumor 2 Control treated glucoco…
- GSM8728823 Control treated glucocorticoid receptor knockout (GRKO) tumor 3 Control treated glucoco…
- GSM8728824 Control treated glucocorticoid receptor knockout (GRKO) tumor 4 Control treated glucoco…
- GSM8728825 Control treated glucocorticoid receptor knockout (GRKO) tumor 5 Control treated glucoco…
- GSM8728826 Glucocorticoid treated glucocorticoid receptor knockout (GRKO) tumor 1 Glucocorticoid treated …
- GSM8728827 Glucocorticoid treated glucocorticoid receptor knockout (GRKO) tumor 2 Glucocorticoid treated …
- GSM8728828 Glucocorticoid treated glucocorticoid receptor knockout (GRKO) tumor 3 Glucocorticoid treated …
- GSM8728829 Glucocorticoid treated glucocorticoid receptor knockout (GRKO) tumor 4 Glucocorticoid treated …
- GSM8728830 Glucocorticoid treated glucocorticoid receptor knockout (GRKO) tumor 5 Glucocorticoid treated …
- GSM8728831 In vitro Control treated parental tumor cells 1 In vitro Control treate…
- GSM8728832 In vitro Control treated parental tumor cells 2 In vitro Control treate…
- GSM8728833 In vitro Control treated parental tumor cells 3 In vitro Control treate…
- GSM8728834 In vitro glucocorticoid treated parental tumor cells 1 In vitro glucocorticoid…
- GSM8728835 In vitro glucocorticoid treated parental tumor cells 2 In vitro glucocorticoid…
- GSM8728836 In vitro Control treated glucocorticoid receptor knockout tumor cells 1 In vitro Control treate…
- GSM8728837 In vitro Control treated glucocorticoid receptor knockout tumor cells 2 In vitro Control treate…
- GSM8728838 In vitro Control treated glucocorticoid receptor knockout tumor cells 3 In vitro Control treate…
- GSM8728839 In vitro glucocorticoid treated glucocorticoid receptor knockout tumor cells 1 In vitro glucocorticoid…
- GSM8728840 In vitro glucocorticoid treated glucocorticoid receptor knockout tumor cells 2 In vitro glucocorticoid…
- GSM8728841 In vitro glucocorticoid treated glucocorticoid receptor knockout tumor cells 3 In vitro glucocorticoid…
- GSE296094 Genomic stratification based on SMAD4 in pancreatic cancer reveals biological implications of aberrant TGFβ signaling and susceptibility to TGFβ inhibition 20 samples shares tgf, inhibition
- GSE268791 TGF-b/Smad3 inhibition synergizes with PPARg agonism to reduce fibrosis and enhance functional beige adipogenesis 18 samples shares tgf, inhibition
- GSE301156 Control and Tgfbr2 cKO Mouse Endometrial Epithelial Organoids +/- E2/MPA Treatment 16 samples shares tgf, control
- GSE272376 A dual TGF-β-driven immunosuppressive mechanism controls T cell recruitment and expansion in metastatic colorectal cancer 12 samples shares tgf, control
- GSE286241 BRAF inhibition increases TGFb2 production and stimulates metastasis in mice with endogenous BRAFV600E-induced hepatocellular carcinoma 12 samples shares tgf, inhibition
- GSE285576 Comparison of otic vesicle gene expression from E10.5 mouse and inner ear organoid cultures at 12 days-in-vitro with (BSFL) and without (BFL) TGFβ inhibition 11 samples shares tgf, inhibition
- GSE75111 Single-cell transcriptional profiling of Th17 cells, differentiated in vitro for 48h [TGFB1_IL6-48h-IL-17A/GFP+] 151 samples shares tgf
- GSE75110 Single-cell transcriptional profiling of Th17 cells, differentiated in vitro for 48h [TGFB1_IL6-48h] 130 samples shares tgf
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.